TDAC

NASDAQ

Translational Development Acquisition Corp.

IPO2025

News25/Ratings1

Trident Acquisitions Corp. does not have significant operations. It intends to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more target businesses primarily in the oil and gas or other natural resource sector. Trident Acquisitions Corp. was incorporated in 2016 and is headquartered in New York, New York.

News · 26 weeks2+100%

2025-10-262026-04-19

Mix190d

SEC Filings1(100%)

Latest news

25 items

24dSEC
SEC Form 10-K filed by Translational Development Acquisition Corp.
10-K - Translational Development Acquisition Corp. (0001926599) (Filer)
160dSEC
SEC Form 10-Q filed by Translational Development Acquisition Corp.
10-Q - Translational Development Acquisition Corp. (0001926599) (Filer)
195dSEC
Amendment: SEC Form SCHEDULE 13G/A filed by Translational Development Acquisition Corp.
SCHEDULE 13G/A - Translational Development Acquisition Corp. (0001926599) (Subject)
252dSEC
Translational Development Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits
8-K - Translational Development Acquisition Corp. (0001926599) (Filer)
252dSEC
SEC Form 10-Q filed by Translational Development Acquisition Corp.
10-Q - Translational Development Acquisition Corp. (0001926599) (Filer)
266dSEC
Amendment: SEC Form SCHEDULE 13G/A filed by Translational Development Acquisition Corp.
SCHEDULE 13G/A - Translational Development Acquisition Corp. (0001926599) (Subject)
286dSEC
Amendment: SEC Form SCHEDULE 13G/A filed by Translational Development Acquisition Corp.
SCHEDULE 13G/A - Translational Development Acquisition Corp. (0001926599) (Subject)
343dSEC
SEC Form 10-Q filed by Translational Development Acquisition Corp.
10-Q - Translational Development Acquisition Corp. (0001926599) (Filer)
344dSEC
Amendment: SEC Form SCHEDULE 13G/A filed by Translational Development Acquisition Corp.
SCHEDULE 13G/A - Translational Development Acquisition Corp. (0001926599) (Subject)
344dSEC
Amendment: SEC Form SCHEDULE 13G/A filed by Translational Development Acquisition Corp.
SCHEDULE 13G/A - Translational Development Acquisition Corp. (0001926599) (Subject)
350dSEC
SEC Form SCHEDULE 13G filed by Translational Development Acquisition Corp.
SCHEDULE 13G - Translational Development Acquisition Corp. (0001926599) (Subject)
357dSEC
SEC Form SCHEDULE 13G filed by Translational Development Acquisition Corp.
SCHEDULE 13G - Translational Development Acquisition Corp. (0001926599) (Subject)
388dSEC
SEC Form 10-K filed by Translational Development Acquisition Corp.
10-K - Translational Development Acquisition Corp. (0001926599) (Filer)
433dSEC
Translational Development Acquisition Corp. filed SEC Form 8-K: Financial Statements and Exhibits
8-K - Translational Development Acquisition Corp. (0001926599) (Filer)
433dSEC
SEC Form SCHEDULE 13G filed by Translational Development Acquisition Corp.
SCHEDULE 13G - Translational Development Acquisition Corp. (0001926599) (Subject)
433dSEC
SEC Form SCHEDULE 13G filed by Translational Development Acquisition Corp.
SCHEDULE 13G - Translational Development Acquisition Corp. (0001926599) (Subject)
449dSEC
SEC Form SCHEDULE 13G filed by Trident Acquisitions Corp.
SCHEDULE 13G - Translational Development Acquisition Corp. (0001926599) (Subject)
472dINSIDER
SEC Form 3 filed by new insider Jarratt Christopher Kenneth
3 - Translational Development Acquisition Corp. (0001926599) (Issuer)
478dSEC
Trident Acquisitions Corp. filed SEC Form 8-K: Financial Statements and Exhibits
8-K - Translational Development Acquisition Corp. (0001926599) (Filer)
482dSEC
Trident Acquisitions Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
8-K - Translational Development Acquisition Corp. (0001926599) (Filer)
486dSEC
SEC Form 424B4 filed by Trident Acquisitions Corp.
424B4 - Translational Development Acquisition Corp. (0001926599) (Filer)
487dSEC
SEC Form EFFECT filed by Trident Acquisitions Corp.
EFFECT - Translational Development Acquisition Corp. (0001926599) (Filer)
489dINSIDER
SEC Form 3 filed by new insider Keith Curtis T
3 - Translational Development Acquisition Corp. (0001926599) (Issuer)
489dINSIDER
SEC Form 3 filed by new insider Tdac Partners Llc
3 - Translational Development Acquisition Corp. (0001926599) (Issuer)
489dINSIDER
SEC Form 3 filed by new insider Reddy E Premkumar
3 - Translational Development Acquisition Corp. (0001926599) (Issuer)